CNO FINANCIAL GROUP INC (CNO)
US12621E1038 - Common Stock
We assign a fundamental rating of 3 out of 10 to CNO. CNO was compared to 141 industry peers in the Insurance industry. CNO has a medium profitability rating, but doesn't score so well on its financial health evaluation. CNO has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
CNO had positive earnings in the past year.
In the past year CNO had a positive cash flow from operations.
In the past 5 years CNO has always been profitable.
In the past 5 years CNO always reported a positive cash flow from operatings.
1.2 Ratios
CNO has a Return On Assets (0.79%) which is in line with its industry peers.
CNO has a Return On Equity of 12.48%. This is in the better half of the industry: CNO outperforms 60.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.79% | ||
| ROE | 12.48% | ||
| ROIC | N/A |
ROA(3y)1.42%
ROA(5y)1.27%
ROE(3y)19.66%
ROE(5y)14.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CNO has a Profit Margin of 6.56%. This is comparable to the rest of the industry: CNO outperforms 56.12% of its industry peers.
In the last couple of years the Profit Margin of CNO has declined.
The Operating Margin of CNO (15.26%) is better than 70.50% of its industry peers.
In the last couple of years the Operating Margin of CNO has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.26% | ||
| PM (TTM) | 6.56% | ||
| GM | N/A |
OM growth 3Y7.5%
OM growth 5YN/A
PM growth 3Y-5.86%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
Compared to 1 year ago, CNO has less shares outstanding
Compared to 5 years ago, CNO has less shares outstanding
Compared to 1 year ago, CNO has a worse debt to assets ratio.
2.2 Solvency
The Debt to FCF ratio of CNO is 7.12, which is on the high side as it means it would take CNO, 7.12 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 7.12, CNO is not doing good in the industry: 68.35% of the companies in the same industry are doing better.
CNO has a Debt/Equity ratio of 1.87. This is a high value indicating a heavy dependency on external financing.
CNO's Debt to Equity ratio of 1.87 is on the low side compared to the rest of the industry. CNO is outperformed by 92.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.87 | ||
| Debt/FCF | 7.12 | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 34.05% over the past year.
The Earnings Per Share has been growing by 12.32% on average over the past years. This is quite good.
The Revenue has grown by 17.29% in the past year. This is quite good.
Measured over the past years, CNO shows a decrease in Revenue. The Revenue has been decreasing by -0.47% on average per year.
EPS 1Y (TTM)34.05%
EPS 3Y7.12%
EPS 5Y12.32%
EPS growth Q2Q110.71%
Revenue 1Y (TTM)17.29%
Revenue growth 3Y3.17%
Revenue growth 5Y-0.47%
Revenue growth Q2Q18.76%
3.2 Future
CNO is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.83% yearly.
Based on estimates for the next years, CNO will show a small growth in Revenue. The Revenue will grow by 3.55% on average per year.
EPS Next Y2.09%
EPS Next 2Y5.67%
EPS Next 3Y5.83%
EPS Next 5YN/A
Revenue Next Year3.45%
Revenue Next 2Y3.03%
Revenue Next 3Y3.55%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CNO is valuated reasonably with a Price/Earnings ratio of 8.50.
67.63% of the companies in the same industry are more expensive than CNO, based on the Price/Earnings ratio.
CNO is valuated cheaply when we compare the Price/Earnings ratio to 25.20, which is the current average of the S&P500 Index.
CNO is valuated reasonably with a Price/Forward Earnings ratio of 8.33.
Based on the Price/Forward Earnings ratio, CNO is valued a bit cheaper than 66.91% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.63, CNO is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.5 | ||
| Fwd PE | 8.33 |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, CNO is valued a bit cheaper than 72.66% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.93 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)4.06
PEG (5Y)0.69
EPS Next 2Y5.67%
EPS Next 3Y5.83%
5. Dividend
5.1 Amount
CNO has a Yearly Dividend Yield of 2.34%.
CNO's Dividend Yield is a higher than the industry average which is at 4.35.
Compared to an average S&P500 Dividend Yield of 2.44, CNO has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.34% |
5.2 History
The dividend of CNO is nicely growing with an annual growth rate of 9.10%!
CNO has been paying a dividend for at least 10 years, so it has a reliable track record.
CNO has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)9.1%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
24.63% of the earnings are spent on dividend by CNO. This is a low number and sustainable payout ratio.
The dividend of CNO is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP24.63%
EPS Next 2Y5.67%
EPS Next 3Y5.83%
CNO FINANCIAL GROUP INC
NYSE:CNO (4/25/2024, 7:04:00 PM)
After market: 26.45 0 (0%)26.45
-0.44 (-1.64%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.87B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.34% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.5 | ||
| Fwd PE | 8.33 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)4.06
PEG (5Y)0.69
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.79% | ||
| ROE | 12.48% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 15.26% | ||
| PM (TTM) | 6.56% | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.87 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)34.05%
EPS 3Y7.12%
EPS 5Y
EPS growth Q2Q
EPS Next Y2.09%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)17.29%
Revenue growth 3Y3.17%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y